1. Home
  2. LUNG vs AIRS Comparison

LUNG vs AIRS Comparison

Compare LUNG & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • AIRS
  • Stock Information
  • Founded
  • LUNG 1995
  • AIRS 2012
  • Country
  • LUNG United States
  • AIRS United States
  • Employees
  • LUNG N/A
  • AIRS N/A
  • Industry
  • LUNG Industrial Specialties
  • AIRS Medical/Nursing Services
  • Sector
  • LUNG Health Care
  • AIRS Health Care
  • Exchange
  • LUNG Nasdaq
  • AIRS Nasdaq
  • Market Cap
  • LUNG 248.0M
  • AIRS 302.9M
  • IPO Year
  • LUNG 2020
  • AIRS 2021
  • Fundamental
  • Price
  • LUNG $6.95
  • AIRS $5.41
  • Analyst Decision
  • LUNG Strong Buy
  • AIRS Hold
  • Analyst Count
  • LUNG 7
  • AIRS 2
  • Target Price
  • LUNG $13.71
  • AIRS $5.50
  • AVG Volume (30 Days)
  • LUNG 203.3K
  • AIRS 135.0K
  • Earning Date
  • LUNG 10-28-2024
  • AIRS 11-07-2024
  • Dividend Yield
  • LUNG N/A
  • AIRS N/A
  • EPS Growth
  • LUNG N/A
  • AIRS N/A
  • EPS
  • LUNG N/A
  • AIRS N/A
  • Revenue
  • LUNG $76,583,000.00
  • AIRS $193,025,000.00
  • Revenue This Year
  • LUNG $22.73
  • AIRS N/A
  • Revenue Next Year
  • LUNG $19.02
  • AIRS $11.85
  • P/E Ratio
  • LUNG N/A
  • AIRS N/A
  • Revenue Growth
  • LUNG 26.26
  • AIRS 6.58
  • 52 Week Low
  • LUNG $5.46
  • AIRS $2.92
  • 52 Week High
  • LUNG $14.84
  • AIRS $8.30
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.63
  • AIRS 57.23
  • Support Level
  • LUNG $6.39
  • AIRS $4.62
  • Resistance Level
  • LUNG $6.92
  • AIRS $6.16
  • Average True Range (ATR)
  • LUNG 0.34
  • AIRS 0.45
  • MACD
  • LUNG -0.14
  • AIRS 0.02
  • Stochastic Oscillator
  • LUNG 16.10
  • AIRS 55.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.

Share on Social Networks: